Preddie et al. have investigated whether the immunosuppressant mycophenolate mofetil (MMF) could be useful in such patients. The study included eight patients with biopsy-proven AIN who had ...

Mycophenolate mofetil and mycophenolate sodium are now the antimetabolites of choice. A new class of drugs (inhibitors of mammalian target of rapamycin) that includes sirolimus is being ...

mycophenolate mofetil is not superior to azathioprine in preventing acute rejection after renal transplantation. Mycophenolate is, however, more expensive than azathioprine. Objective: To compare ...

mycophenolate mofetil. EC mycophenolate sodium was developed to reduce the upper-gastrointestinal (GI) effects of mycophenolate mofetil. Unlike oral mycophenolate mofetil, which releases MPA in ...